Identification of a gene on human chromosome 8q11 that is differentially expressed during prostate-cancer progression

International Journal of Cancer

Volumn 83, Issue 4, 1999, Pages 506-511

  Chang, Glenn T G ^a   Tapsi, Nita ^a   Steenbeek, Martine ^a   Blok, Leen J ^a   Van Weerden, Wytske M ^b   Van Alewijk, Dirk C J G ^b   Eussen, Bert H J ^a   Van Steenbrugge, Gert J ^b   Brinkmann, Albert O ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 8Q; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTO ONCOGENE; SEQUENCE ANALYSIS;

ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; CARCINOMA; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 8; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; MALE; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0032832349     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991112)83:4<506::AID-IJC12>3.0.CO;2-0     Document Type: Article

References (26)

1. BERGERHEIM, U.S.R., KUMINI, K., COLLINS, V.P. and ECKMAN, P., Deletion mapping of chromosomes 8, 10 and 16 in human prostatic carcinoma. Genes Chromosomes Cancer, 3, 215-220 (1991).
2. BOOKSTEIN, R., RIO, P., MADREPERLA, S.A., HONG, F., ALLRED, C., GRIZZLE, W.E. and LEE, W.H., Promoter deletion and loss of retinoblastoma expression in human prostate carcinoma. Proc. nat. Acad. Sci. (Wash.), 87, 7762-7766 (1990).
3. BOVA, G.S., CARTER, B.S., BUSSEMAKERS, M.J.G., EMI, M., FUJIWARA, Y., KYPRIANOU, N., JACOBS, S.C., ROBINSON, J.C., EPSTEIN, J.I., WALSH, P.C. and ISAACS, W.B., Homozygous deletion and frequent alleleic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res., 53, 3869-3873 (1993).
4. BROWN, D.D., WANG, Z., FURLOW, J.D., KANAMORI, A., SCHWARTZMAN, R.A., REMO, B.F. and PINDER, A., The thyroid-hormone-induced tail resorption program during Xenopus laevis metamorphosis. Proc. nat. Acad. Sci. (Wash.), 94, 1924-1929 (1996).
5. CHANG, G.T.G., BLOK, L.J., STEENBEEK, M., VELDSCHOLTE, J., VAN WEERDEN, W.M., VAN STEENBRUGGE, G.J. and BRINKMANN, A.O., Differentially expressed genes in androgen-dependent and - independent prostate carcinomas. Cancer Res., 57, 4075-4081 (1997).
6. CHER, M.L., BOVA, G.S., MOORE, D.H., SMALL, E.J., CARROLL, P.R., PIN, S.S., EPSTEIN, J.I., ISAACS, W.B. and JENSEN, R.H., Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res., 56, 3091-3102 (1996).
7. COFFEY, D.S., Prostate cancer. An overview of an increasing dilemma. Cancer, 71, 880-886 (1993).
8. DONG, J.T., LAMB, P.W., RINKER-SCHAEFFER, C.W., VUKANOVIC, J., ICHIKAWA, T., ISAACS, J.T. and BARRETT, J.C., KA11, a metastasis-suppressor gene for prostate cancer on human chromosome 11p11.2. Science, 268, 884-886 (1995).
9. DONLON, T., WYMAN, A.R., MULHOLLAND, J., BARKER, D., BRUNS, G., LATT, S. and BOTSTEIN, D., Alpha-satellite-like sequences at the centromere of chromosome 8. Amer. J. hum. Genet., 39, 196 (1986).
10. EAGLE, L.R., YIN, X., BROTMAN, A.R., WILLIAMS, B.J., ATKIN, N.B. and PROCHOWNIK, E.V., Mutations of the Mxil gene in prostate cancer. Nature Genet., 9,249-255 (1995).
11. FEARON, E. R. and VOOELSTEIN, B., A genetic model for colorectal tumorigenesis. Cell, 61, 759-767 (1990).
12. HAYWARD, S.W., CUNHA, G.R. and DAHIYA. R., Normal development and carcinogenesis of the prostate. A unifying hypothesis. Ann. N.Y. Acad. Sci., 784,50-62 (1996).
13. HUGGINS, C. and HODGES, C.V., Studies on prostate cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res., 1, 293-297 (1941).
14. ISRAELI, R.S., POWELL, C.T., CORR, J.G., FAIR, W.R. and HESTON, W.D.W., Expression of the prostate-specific membrane antigen. Cancer Res., 54, 1807-1811 (1994).
15. JENKINS, R.B., QIAN, J., LIEBER, M.M. and BOSTWICK, D.G., Detection of c-myc-oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res., 57, 524-531 (1997).
16. KÖNIG, J.J., TEUBEL, W., VAN STEENBRUGGE, G.J., ROMIJN, J.C. and HAGEMEUER, A., Characterization of chromosome-8 aberrations in the prostate-cancer cell line LNCaP-FGC and sub-lines. Uro. Res., 27, 3-8 (1999).
17. Li, J. and 16 OTHERS., PTEN, a putative protein-phosphatase gene mutated in human brain, breast and prostate cancer. Science, 275, 1943-1947 (1997).
18. McDONNELL, T.J., TRONCOSO, P. and BRISBY, S.M., Expression of the proto-oncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res., 52, 6940-6944 (1992).
19. NUPPONEN, N.N., KAKKOLA, L., KOIVISTO, P. and VISAKORPI, T., Genetic alterations in hormone-refractory recurrent prostate carcinomas. Amer. J. Pathol., 153, 141-148 (1998).
20. REITER, R.E., GU, Z., WATABE, T., THOMAS, G., SZIGETI, K., DAVIS, E., WAHL, M.. NISITANI, S., YAMASHIRO, J., LE BEAU, M.M., LODA, M. and WITTE, O.N., Prostate stem-cell antigen: a cell-surface marker over-expressed in prostate cancer. Proc. not. Acad. Sci. (Wash.), 95, 1735-1740 (1998).
21. SHENG, S., CAREY, J., SEFTOR, E.A., DIAS, L., HENDRIX, M.J. and SAGER, R., Maspin acts at the cell membrane to inhibit invasion and motility of mammary- and prostatic-cancer cells. Proc. nat. Acad. Sci. (Wash.), 93, 11669-11674 (1996).
22. STUDLER, J.M., GLOWINSKI, J. and LÉVI-STRAUSS, M., An abundant mRNA of the embryonic brain persists at high level in cerebellum, hippocampus and olfactory bulb during adulthood. Europ. J. Neurosci., 5, 614-623 (1993).
23. VAN WEERDEN, W.M., DE RIDDER, C.M.A., VERDAASDONK, C.L., ROMIJN, J.C., VAN DER KWAST, TH.H., SCHRÖDER, F.H. and VAN STEENBRUGGE, G.J., Seven newly developed human prostate-tumor xenograft models: establishment and histopathological characterization. Amer. J. Pathol, 149, 1055-1062 (1996).
24. VISAKORPI, T., KALLIONIEMI, O.P., HEIKKINEN, A., KOIVULA, T. and ISOLA, J., Small sub-group of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation. J. nat. Cancer Inst., 84, 883-887 (1992).
25. VISAKORPI, T., KALLIONIEMI, A.H., SYVÄNEN, A.C., HYYTINEN, E.R., KARHU, R., TAMMELA, T., ISOLA, J.J. and KALLIONIEMI, O.P., Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res., 55, 342-347 (1995).
26. YOUNG, C.Y.F., MONTGOMERY, B.T., ANDREWS. P.E., QIU, S., BILHARTZ, D.L. and TINDALL, D.J., Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic-adenocarcinoma cell line LNCaP. Cancer Res., 51, 3748-3752 (1991).